Related Experiment Video
Updated: Aug 23, 2026
T-maze Forced Alternation and Left-right Discrimination Tasks for Assessing Working and Reference Memory in Mice
Published on: February 26, 2012
Abstract:
Ultrastructural study of the Jimpy mice shows lack of myelin in the central nervous system: low density of glial cells, defect of maturation of oligodendrocytes and deficiency in axonal growth. The lack of myelin is more proeminent in late myelinating structures: corpus callosum and corticospinal fasciculus. Failure in myelin is rather the consequence of an early interruption of myelination as that of demyelination (a destruction of the sheats).
Insights
Jimpy mice exhibit a severe lack of myelin in the central nervous system due to impaired oligodendrocyte maturation and axonal growth. This myelin deficiency, particularly in late-myelinating regions, suggests an early interruption of the myelination process.
Area of Science:
- Neuroscience
- Cell Biology
- Developmental Biology
Context:
- The Jimpy mouse model is utilized to investigate genetic disorders affecting myelin.
- Understanding the cellular and molecular basis of myelin formation is crucial for neurological health.
Purpose:
- To conduct an ultrastructural analysis of the Jimpy mouse central nervous system.
- To identify the specific cellular defects contributing to the observed hypomyelination.
Summary:
- Ultrastructural examination of Jimpy mice reveals a profound lack of central nervous system myelin.
- Key findings include a low density of glial cells, defective oligodendrocyte maturation, and impaired axonal growth.
- The hypomyelination is most pronounced in the corpus callosum and corticospinal fasciculus, indicating a failure in late myelination stages.
Impact:
- This study elucidates the cellular pathology underlying the Jimpy mouse phenotype, offering insights into myelination failure.
- The findings suggest that the primary issue is an early interruption of myelination rather than secondary demyelination.
- This research contributes to understanding the complex processes of myelin development and potential therapeutic targets for myelin disorders.
